The BCL2L11 deletion polymorphism is not associated with imatinib resistance in chronic myeloid leukemia patients: meta-analysis

A common deletion polymorphism of the gene Bcl-2 like protein 11 (BCL2L11, BIM) has been reported to cause tyrosine kinase inhibitors (TKIs) resistance in several malignant tumors. However, the conclusions were not consistent in chronic myeloid leukemia (CML) individuals. In order to obtain a reliab...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jinyun, Gu, Jiaowei, Zhao, Yan, Meng, Huihua, Du, Li’an, Zhang, Ruibo, Jiang, Hao, Luo, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716789/
https://www.ncbi.nlm.nih.gov/pubmed/29228749
http://dx.doi.org/10.18632/oncotarget.21154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716789/
https://www.ncbi.nlm.nih.gov/pubmed/29228749
http://dx.doi.org/10.18632/oncotarget.21154

Ejemplares similares